REVELSTOKE CAPITAL PARTNERS

REVELSTOKE CAPITAL PARTNERS is a Series C+ and buyout fund in the US writing $10M–$250M checks into healthcare-services, healthcare-tech and health-and-wellness.

Stages: Series C+, buyout
Sectors: healthcare-services, healthcare-tech, health-and-wellness
Check size: $10M–$250M
Invests in: US-wide
Round role: Leads rounds
Actively investing: Yes
Founded: 2013
Assets under management: $6.8B
Website: revelstokecapital.com

Thesis

Revelstoke Capital Partners is a private equity firm founded in 2013 and headquartered in Denver, Colorado. They specialize in the healthcare services, healthcare technology, and health and wellness sectors, with a primary geographic focus on the United States. Their investment strategy centers on partnering with entrepreneurs and management teams to accelerate growth and improve outcomes within the healthcare industry. Revelstoke prefers control transactions and focuses on companies with strong organic growth potential, demonstrated profitability, and non-discretionary or recurring services. They employ a research-driven, thematic approach to identify high-growth segments and utilize an in-house Portfolio Transformation Group to provide operational expertise and resources for value creation. This includes facilitating growth through strategic add-on acquisitions, de-novo openings, sales force development, and geographic expansion. As of August 2023, the firm had approximately $5.8 billion in AUM, with more recent reports indicating $6.8 billion. They typically invest between $10 million and $250 million per deal. Their strategy suggests a focus on growth equity to buyout stages.

Common questions

Does REVELSTOKE CAPITAL PARTNERS invest at the Series C+ stage?

Yes. REVELSTOKE CAPITAL PARTNERS lists Series C+ and buyout among the stages it invests in.

What check size does REVELSTOKE CAPITAL PARTNERS write?

REVELSTOKE CAPITAL PARTNERS writes $10M–$250M checks.

Where does REVELSTOKE CAPITAL PARTNERS invest?

REVELSTOKE CAPITAL PARTNERS invests in the US.